These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1421 related items for PubMed ID: 10560951

  • 1. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K, Yamazaki K, Yamada E, Kanaji Y, Miura M, Obara T.
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [Abstract] [Full Text] [Related]

  • 2. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
    Takasu N, Yamashiro K, Komiya I, Ochi Y, Sato Y, Nagata A.
    Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
    [Abstract] [Full Text] [Related]

  • 3. [Clinical studies on abnormal thyroid stimulators in patients with Graves' disease. I. A sensitive assay for thyroid-stimulating antibodies using cultured porcine thyroid cells and polyethylene glycol precipitation of serum].
    Uno C, Nishikawa M.
    Nihon Naibunpi Gakkai Zasshi; 1988 Mar 20; 64(3):193-205. PubMed ID: 2899523
    [Abstract] [Full Text] [Related]

  • 4. Demonstration of anti-TSH antibody in TSH binding inhibitory immunoglobulin-positive sera of patients with Graves' disease.
    Ochi Y, Hamazu M, Kajita Y, Nagata A.
    Clin Endocrinol (Oxf); 2002 Mar 20; 56(3):405-12. PubMed ID: 11940054
    [Abstract] [Full Text] [Related]

  • 5. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
    Chen W, Man N, Li YS, Shan ZY, Teng WP.
    Zhonghua Nei Ke Za Zhi; 2006 Feb 20; 45(2):95-9. PubMed ID: 16624113
    [Abstract] [Full Text] [Related]

  • 6. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
    Tamaki H, Amino N, Aozasa M, Mori M, Tanizawa O, Miyai K.
    J Clin Endocrinol Metab; 1987 Aug 20; 65(2):324-30. PubMed ID: 2885336
    [Abstract] [Full Text] [Related]

  • 7. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY, Hamada N, Inoue Y, Abe Y, Ito K, Ito K.
    Thyroid; 2000 Sep 20; 10(9):809-13. PubMed ID: 11041459
    [Abstract] [Full Text] [Related]

  • 8. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
    Takasu N, Oshiro C, Akamine H, Komiya I, Nagata A, Sato Y, Yoshimura H, Ito K.
    J Endocrinol Invest; 1997 Sep 20; 20(8):452-61. PubMed ID: 9364248
    [Abstract] [Full Text] [Related]

  • 9. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
    Takasu N, Kamijo K, Sato Y, Yoshimura H, Nagata A, Ochi Y.
    Clin Exp Pharmacol Physiol; 2004 Sep 20; 31(5-6):314-9. PubMed ID: 15191404
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of TSH receptor antibody by 'natural in vivo human assay' in neonates born to mothers with Graves' disease.
    Tamaki H, Amino N, Iwatani Y, Tachi J, Kimura M, Mitsuda N, Ichihara K, Tanizawa O, Miyai K.
    Clin Endocrinol (Oxf); 1989 May 20; 30(5):493-503. PubMed ID: 2575017
    [Abstract] [Full Text] [Related]

  • 11. Differences in TSH receptor binding and thyroid-stimulating properties between TSH and Graves' IgG. Slowly-acting TSH receptor antibody moieties in Graves' sera affect assay data.
    Saiki Y, Ishihara T, Ikekubo K, Mori T.
    Endocr J; 2005 Feb 20; 52(1):45-55. PubMed ID: 15758557
    [Abstract] [Full Text] [Related]

  • 12. Evidence against the importance in the disease process of antibodies to bovine thyroid-stimulating hormone found in some patients with Graves' disease.
    Noh J, Hamada N, Saito H, Oyanagi H, Ishikawa N, Momotani N, Ito K, Morii H.
    J Clin Endocrinol Metab; 1989 Jan 20; 68(1):107-13. PubMed ID: 2909548
    [Abstract] [Full Text] [Related]

  • 13. Augmentation of thyroid-stimulating antibody-stimulated cyclic adenosine monophosphate response by polyethylene glycol, polyvinyl alcohol, and dextran; highly sensitive porcine thyroid cell thyroid-stimulating antibody assay.
    Yamashiro K, Takasu N, Kouki T, Inui T, Ochi Y, Kajita Y, Sato Y, Nagata A.
    Thyroid; 1999 Mar 20; 9(3):263-71. PubMed ID: 10211603
    [Abstract] [Full Text] [Related]

  • 14. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK, Plicht M, Lax H, Hirche H, Quadbeck B, Mann K, Steuhl KP, Esser J, Morgenthaler NG.
    Clin Endocrinol (Oxf); 2004 Nov 20; 61(5):612-8. PubMed ID: 15521965
    [Abstract] [Full Text] [Related]

  • 15. Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor.
    Morgenthaler NG, Pampel I, Aust G, Seissler J, Scherbaum WA.
    Horm Metab Res; 1998 Mar 20; 30(3):162-8. PubMed ID: 9566861
    [Abstract] [Full Text] [Related]

  • 16. Studies on thyrotrophin receptor antibodies in patients with euthyroid Graves' disease.
    Kasagi K, Hatabu H, Tokuda Y, Iida Y, Endo K, Konishi J.
    Clin Endocrinol (Oxf); 1988 Oct 20; 29(4):357-66. PubMed ID: 2908031
    [Abstract] [Full Text] [Related]

  • 17. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.
    Maugendre D, Massart C.
    Clin Endocrinol (Oxf); 2001 Jan 20; 54(1):89-96. PubMed ID: 11167931
    [Abstract] [Full Text] [Related]

  • 18. Assays for thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins in children with Graves' disease.
    Shibayama K, Ohyama Y, Yokota Y, Ohtsu S, Takubo N, Matsuura N.
    Endocr J; 2005 Oct 20; 52(5):505-10. PubMed ID: 16284425
    [Abstract] [Full Text] [Related]

  • 19. Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody.
    Ochi Y, Kajita Y, Hamazu M, Nagata A.
    Horm Res; 2003 Oct 20; 59(5):222-8. PubMed ID: 12714785
    [Abstract] [Full Text] [Related]

  • 20. Anti-bovine TSH antibodies in patients with Graves' disease and primary myxedema.
    Cho BY, Shong YK, Lee HK, Koh CS, Min HK.
    Thyroidology; 1989 Apr 20; 1(1):31-7. PubMed ID: 2484905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 72.